Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
See All Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
Rosenbaum C, Bird SB. Timing and frequency of physostigmine redosing for antimuscarinic toxicity. J Med Toxicol. 2010 Dec; 6(4):386-92.
View in:
PubMed
subject areas
Adult
Akathisia, Drug-Induced
Autonomic Nervous System
Cholinesterase Inhibitors
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Length of Stay
Male
Middle Aged
Muscarinic Antagonists
Neurotoxicity Syndromes
Physostigmine
Retrospective Studies
Treatment Outcome
Young Adult
authors with profiles
Steven B Bird MD